3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Active not recruiting
3
Recruiting
2
Terminated
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
1
Breast
1
Conditions
Radiation Injuries
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Breast Neoplasms
1
Interventions
Specimen Handling
313
Magnetic Resonance Spectroscopy
272
pembrolizumab
263
Carboplatin
190
Cyclophosphamide
177
Biopsy
177
Cisplatin
165
Paclitaxel
137
Gemcitabine
137
Bevacizumab
122
fludarabine
115
Nivolumab
114
Radiotherapy
111
venetoclax
98
Oxaliplatin
97
Fluorouracil
87
Docetaxel
85
Dexamethasone
83
Capecitabine
83
Pemetrexed
76
Drug Therapy
76
Rituximab
75
Leucovorin
71
durvalumab
70
Radiosurgery
67
Doxorubicin
64
Blood Specimen Collection
64
Standard of Care
63
Injections
62
atezolizumab
61
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Lymph Node Excision
×
90 days
×
Clear all
NCT04889924
2026-05-19
ADARNAT
Hospital Universitari de Bellvitge
Phase NA
Recruiting
820 enrolled
NCT07519486
2026-04-15
INS-ESCC-CT
Sichuan University
Phase 2
Recruiting
118 enrolled